Titre:
  • Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial.
Auteur:Bogaerts, J; Cardoso, Fatima; Buyse, Marc; Braga, S; Loi, Sherene; Harrison, Jillian A; Bines, Jacques; Mook, Stella; Decker, Nuria; Ravdin, Peter; Therasse, P.; Rutgers, Emiel; Van't Veer, Laura; Piccart-Gebhart, Martine; TRANSBIG Consortium,
Informations sur la publication:Nature clinical practice. Oncology, 3, 10, page (540-551)
Statut de publication:Publié, 2006-10
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Breast Neoplasms -- drug therapy
Breast Neoplasms -- genetics
Breast Neoplasms -- surgery
Chemotherapy, Adjuvant
Endpoint Determination
Female
Gene Expression Profiling
Humans
Multicenter Studies as Topic
Oligonucleotide Array Sequence Analysis
Prognosis
Randomized Controlled Trials as Topic
Research Design
Sample Size
Note générale:Journal Article
Review
Langue:Anglais
Identificateurs:urn:issn:1743-4262
info:doi/10.1038/ncponc0591
info:pii/ncponc0591
info:scp/33750601244
info:pmid/17019432